<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:CATB (USA) Also Trade In: Germany

Catabasis Pharmaceuticals Inc $ 4.73 -0.02 (-0.42%)

Volume:
42,752
Avg Vol (1m):
73,085
Market Cap $:
54.96 Mil
Enterprise Value $:
10.12 Mil
P/E (TTM):
0.00
P/B:
1.24
Warning! GuruFocus has detected 3 Severe warning signs with CATB. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

5.6/10
Current Vs Industry Vs History
Cash-To-Debt 36.42
Debt-to-Equity 0.03
Debt-to-EBITDA -0.05
N/A
Piotroski F-Score 3
0
1
2
3
4
5
6
7
8
9
Beneish M-Score 1.04
Not Manipulator
Manipulator
WACC vs ROIC
ROIC 0%
WACC 11.94%

Profitability

2/10
Current Vs Industry Vs History
ROE % -58.06
ROA % -52.38
ROC (Joel Greenblatt) % -4080.3
3-Year EBITDA Growth Rate 49.4
3-Year EPS without NRI Growth Rate 49.9

Ratios

Current Vs Industry Vs History
PB Ratio 1.24
EV-to-EBIT -0.44
N/A
EV-to-EBITDA -0.44
N/A
Current Ratio 9.09
Quick Ratio 9.09

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -48.9

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 1.25
Earnings Yield (Greenblatt) % -245.49